Brief: Elanix Biotechnologies FY EBIT loss narrows to 2.7 million euros

Elanix Biotechnologies AG

18/04/2017 07:08

April 18 - Elanix Biotechnologies AG  ELNk.F : 
    * Said on Saturday preliminary FY EBITDA according to IFRS 
amounts to a loss of 1.3 million euros ($1.38 million) (2015: 
minus 1.8 million euros) 
    * FY Group EBIT amounted to minus 2.7 million euros (2015: 
minus 3.2 million euros) 
    * Group sales are expected to increase to 0.3 - 0.5 million 
euros, so that a negative group operating result (EBIT) of 3.5 - 
4.0 million euros is expected again in 2017 
    * Provided that it is possible to raise an additional 10 to 
20 million euros by means of suitable capital measures, a 
positive result is expected in the next financial year (2019) 
 
     
 Source text for Eikon:  urn:newsml:reuters.com:*:nEQ6mCy6n 
     
 Further company coverage:  ELNk.F   
    
 
 
 
($1 = 0.9392 euros) 
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))